0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD73

CD73

CD73 Molecule Information

Name:5-nucleotidase
Target Synonym:5 -nucleotidase?NT5E?Ecto-5 -nucleotidase?CD_antigen=CD73?5 -NT?NT5 ?NTE
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Phase ?

CD73 Protein Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
CD3-H82E3 Human Biotinylated Human CD73 / NT5E Protein, His,Avitag™
CD3-H82E3-structure
CD3-H82E3-sds
CD3-H82E3-elisa_1
CD3-M52H9 Mouse Mouse CD73 / NT5E Protein, His Tag
CD3-M52H9-structure
CD3-M52H9-sds
CD3-H52H7 Human Human CD73 / NT5E Protein, His Tag (HPLC-verified)
CD3-H52H7-structure
CD3-H52H7-sds
CD3-H52H7-hplc
CD3-H52H7-elisa_1

cd73 Molecule Synonym Name

CD73,NT5E,5'-Nucleotidase,5'-NT,NT5,NTE

cd73 Molecule Background

5'-nucleotidase also known as NT5E, CD73,

cd73 References

CD73 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
CPI-006 CPI-006 Phase Ⅰ Corvus Triple negative breast cancer, Non small cell lung cancer (NSCLC), Renal cell carcinoma, Endometrial cancer, Squamous cell carcinoma of head and neck cancer (SCCHN), Colorectal cancer, Metastatic castration-resistant prostate cancer (mCRPC), Sarcoma, Bladder cancer, Ovarian cancer, Cervical carcinoma, Pancreatic cancer Details
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb) Phase Ⅰ Bristol-Myers Squibb Cancer Details
TJ-004309 TJ-004309 Phase Ⅰ Tracon Pharma Solid tumours, Metastatic cancer Details
Oleclumab (MedImmune) MEDI-9447 Phase Ⅱ MedImmune Non small cell lung cancer (NSCLC) Details
Anti-CD73 monoclonal antibody (I-MAB Biopharma) TJ-4309; TJD-5,TJ-4309; TJD-5; TJ4309; TJD5 Phase Ⅰ I-MAB Biopharma, Tracon Pharma Solid tumours Details
AB-680 AB-680 Phase Ⅰ Arcus Biosciences Cancer Details
SRF-373 SRF-373; NZV-930 Phase Ⅰ Surface Oncology, Novartis Solid tumours Details

This web search service is supported by Google Inc.

totop